Ads
related to: squamous cell carcinoma- Causes of Sarcoma
Access a Sarcoma Treatment Guide.
Learn About the Causes of Sarcoma.
- Sarcoma Treatment Options
Access a Sarcoma Treatment Guide.
Understand Your Treatment Options.
- Sarcoma Second Opinions
In Need of a Second Opinion?
Our Cancer Answer Line Can Help.
- Schedule an Appointment
Schedule an Appointment Today.
Call Our Cancer Answer Line.
- Virtual Second Opinions
Get Peace of Mind from Home.
Review Your Diagnosis & Treatment.
- Need a Second Opinion?
Put Our Expertise to Work for You.
Get a Virtual Second Opinion Today.
- Causes of Sarcoma
Search results
Q2 2024 EPS Estimates for Janux Therapeutics, Inc. Cut by William Blair (NASDAQ:JANX)
ETF DAILY NEWS· 2 days agoJanux Therapeutics, Inc. (NASDAQ:JANX – Free Report) – Stock analysts at William Blair reduced their Q2 2024 earnings estimates for shares of Janux Therapeutics in a research note issued on ...
AMERICAN ACADEMY OF DERMATOLOGY SURVEY SHOWS OUTDOOR WORKERS MORE AT RISK FOR SKIN CANCER THAN...
The Longview News-Journal· 4 days agoA recent American Academy of Dermatology survey of more than 1,000 U.S. adults revealed that outdoor workers – like those who work in construction, landscaping, emergency medical services, and ...
Pyxis Oncology, Inc. (NASDAQ:PYXS) Receives $8.50 Average Price Target from Brokerages
ETF DAILY NEWS· 7 days agoShares of Pyxis Oncology, Inc. (NASDAQ:PYXS – Get Free Report) have earned an average recommendation of “Buy” from the six brokerages that are currently covering the company, Marketbeat.com ...
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in...
Benzinga· 5 days agoPomerantz LLP announces that a class action lawsuit has been filed against Checkpoint Therapeutics, Inc. ("Checkpoint" or the "Company") CKPT and certain officers. The class action, filed in ...
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in...
Morningstar· 5 days agoPomerantz LLP announces that a class action lawsuit has been filed against Checkpoint Therapeutics, Inc. ("Checkpoint" or the "Company") (NASDAQ: CKPT) and certain officers. The class action ...
Zurcher Kantonalbank Zurich Cantonalbank Has $177,000 Stock Holdings in Castle Biosciences, Inc....
ETF DAILY NEWS· 4 days agoZurcher Kantonalbank Zurich Cantonalbank boosted its stake in Castle Biosciences, Inc. (NASDAQ:CSTL – Free Report) by 20.5% in the fourth quarter, according to the company in its most recent ...
Oncolytics Biotech® Reports First Quarter 2024 Financial Results and Operational Highlights
The Pilot News· 2 days agoPelareorep advancing to registration-enabling studies
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 5 days agoPomerantz LLP announces that a class action lawsuit has been filed against Checkpoint Therapeutics, Inc. ("Checkpoint" or the "Company") (NASDAQ: CKPT) and certain officers. The class action ...